08.26.26 -- Where Should Development Teams Focus To Simplify Downstream Processes?

Membrane design has a direct impact on throughput, formulation integrity, and sustainability. See how better filtration decisions can reduce operational bottlenecks and scale-up risk across processes.

Particles can form or enter during processing, affecting performance. Layered filtration — from early reduction to final polishing — protects operations and improves consistency.

Explore how to maximize the potential of ion exchange resins, as well as practical strategies to improve yield, increase throughput, and enhance process consistency.

Aggregation can undermine yield and quality in downstream mAb processing. Learn practical capture, polishing, and TFF strategies to prevent and reduce aggregates, with a focus on chromatography.

See how high-throughput fusion partner screening identified teriparatide production strains exceeding 6 g/L expression, supporting biosimilar comparability assessment and commercial manufacturing readiness.

Gain insight into how single-pass tangential flow approaches improve efficiency, scalability, and product quality while addressing key development and processing challenges.

Maintaining consistent DAR while reducing risk and variability remains a major ADC challenge. Watch how real‑time spectroscopy replaces dilution‑heavy workflows and strengthens process control.

Discover how integrating inline buffer formulation with chromatography reduces buffer waste by 50% and delivers a 710% ROI, transforming downstream efficiency and sustainability.

Lipid nanoparticles (LNPs) offer a robust solution for nucleic acids. The NanoScaler system optimizes this technology, enabling scalable and reproducible LNP formulations for diverse applications.

Improve lyophilization outcomes by optimizing formulation, cycle parameters, and scale-up strategies to reduce variability and enhance stability across development.

Reducing human intervention is critical for safety and cost efficiency. Delve into why automation is essential for small-batch applications and how it’s transforming sterile drug manufacturing.

Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

Aseptic drug manufacturing is going small. Uncover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Read about how to fortify your processes.